Perakizumab |
| Katalog-Nr.GC72358 |
Perakizumab (RG4934) ist ein humanisierter monoklonaler IgG1κ Antikörper gegen IL-17A (Interleukin Related).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 89957-37-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Perakizumab (RG4934) is a humanized IgG1κ monoclonal antibody against IL-17A (Interleukin Related). Perakizumab can be uesd for the research of autoimmune diseases, such as psoriatic arthritis.
References:
[1]. [1] Dhavalkumar D Patel, et al. Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann Rheum Dis. 2013 Apr;72 Suppl 2:ii116-23.
Review for Perakizumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Perakizumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *